BioAnalytix logo — Advance. De-risk. Accelerate.

BioAnalytix

Advance. De-risk. Accelerate.

Founded 2012 United States Cambridge, United States 6 employees Series Unknown Total: $4.61M Biotechnology, Health Care +1

General Information

Company Name BioAnalytix
Founded Year 2012
Location United States Cambridge, United States +1
Employees 6
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series Unknown
Social

Get notified when BioAnalytix moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About BioAnalytix

BioAnalytix is a biotechnology startup based in the United States, founded in 2012. The company's slogan, "Advance. De-risk. Accelerate." reflects its commitment to collaborating with leading biotherapeutic firms in advancing drug development processes. BioAnalytix specializes in leveraging advanced analytics and data analysis of complex biologics using state-of-the-art mass spectrometry and biophysical analytics. The company's team of PhDs is dedicated to providing precise data packages tailored to specific project needs throughout all stages of biotherapeutic drug development. Moreover, they offer insights and understanding of CMC and regulatory requirements to support product development from IND through BLA. In October 2013, BioAnalytix received a significant $3.75M Venture Round investment from Relativity Healthcare Partners. This capital injection has bolstered the company's ability to continue its mission of revolutionizing biotherapeutic drug development through cutting-edge analytics and expertise.

Taxonomy: Bioanalytix, Biologic Therapeutics, Advanced Analytics, Mass Spec, Drug Development, Biopharma, Regulatory Strategy, CMC, Pharmaceutical, Biophysical Analytics, Method Development, Biosimilar Drugs, Northeastern University, Barnett Institute

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1 •••• •••• 24 Oct 2013
Seed Round •••••• - 17 Aug 2012

BioAnalytix Alternatives & Competitors

BioAnalytix vs

Your RegTech partner in compliance

68 employees
BioAnalytix vs
B2S Life Sciences
B2S Life Sciences United States

We make, characterize and manage critical reagents, develop bioanalytical methods, and offer GLP ana...

45 employees
Biotechnology
BioAnalytix vs
Analytics Intell
Analytics Intell United States

GovAI Coalition member | AI & BI Strategist | Tech Leader | Innovation Consultant Driving Digital Tr...

12 employees
AI, Data Analytics

FAQ About BioAnalytix

Advance. De-risk. Accelerate.
BioAnalytix was founded in 2012.
BioAnalytix is headquartered in Cambridge, United States.
BioAnalytix operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
BioAnalytix has approximately 6 employees.
BioAnalytix has completed 2 funding rounds, raising a total of $4.61M. The latest funding stage is Series Unknown.
Top alternatives and competitors to BioAnalytix include Global Voice Group, B2S Life Sciences, Analytics Intell, Datos Technologies, Blackcoffer. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BioAnalytix and Global Voice Group are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors BioAnalytix and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes